Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 23.3B | 26.2B | 27.7B | 24.7B |
Cost of revenue | 19.0B | 21.1B | 22.1B | 19.6B |
Gross profit | 4.3B | 5.1B | 5.6B | 5.1B |
Operating expense | ||||
Research & development | 840.3M | 1.0B | 996.3M | 979.5M |
Selling general and admin | 1.3B | 1.6B | 1.7B | 1.6B |
Other operating expenses | — | — | — | — |
Operating income | 2.1B | 2.5B | 3.0B | 2.5B |
Non operating interest income | ||||
Income | 211.5M | 299.5M | 268.1M | 336.6M |
Expense | 35.9M | 34.4M | 47.0M | 34.5M |
Other income expense | — | — | — | — |
Pretax income | 2.3B | 3.6B | 3.5B | 3.5B |
Tax provision | 479.8M | 700.3M | 582.1M | 633.2M |
Net income | 1.8B | 2.9B | 2.9B | 2.9B |
Basic EPS | 2.2 | — | 3.3 | 3.4 |
Diluted EPS | 2.2 | — | 3.3 | 3.4 |
Basic average shares | 727.1M | — | 728.6M | 726.7M |
Diluted average shares | 733.8M | — | 733.0M | 731.0M |
EBITDA | 3.0B | 4.3B | 4.2B | 4.2B |
Net income from continuing op. | 2.3B | 3.6B | 3.5B | 3.5B |
Minority interests | -208.4M | -439.6M | -480.9M | -428.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |